US Stock MarketDetailed Quotes

SLXN Silexion Therapeutics

Watchlist
  • 1.173
  • -0.017-1.43%
Trading Mar 26 14:25 ET
10.20MMarket Cap-0.13P/E (TTM)

About Silexion Therapeutics Company

Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.

Company Profile

SymbolSLXN
Company NameSilexion Therapeutics
Listing DateApr 9, 2021
CEOMr. Ilan Hadar
MarketNASDAQ
Employees14
Fiscal Year Ends12-31
Address12 Abba Hillel Road
CityRamat-Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250606
Phone972-8-628-6005

Company Executives

  • Name
  • Position
  • Salary
  • Ilan Hadar
  • Chairman of the Board and Chief Executive Officer
  • 1.54M
  • Mirit Horenshtein Hadar
  • Executive Vice President, Finance Affairs, Chief Financial Officer and Secretary
  • 770.09K
  • Dr. Mitchell Shirvan
  • Chief Scientific and Development Officer
  • 1.30M
  • Avner Lushi
  • Independent Director
  • 313.80K
  • Professor Amnon Peled, PhD
  • Independent Director
  • --
  • Ruth Alon
  • Independent Director
  • 45.00K
  • Shlomo Noy
  • Independent Director
  • 313.80K
  • Ilan Levin
  • Independent Director
  • --
  • Dror J. Abramov
  • Independent Director
  • 313.80K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More